Breast Cancer

Combined Study Analysis Determines Best Drug Choices for Patients with Advanced Breast Cancer
October 21, 2020

Detection of ESR1 mutations in baseline ctDNA was associated with inferior progression-free survival and overall survival in patients with advanced HR-positive breast cancer treated with exemestane versus fulvestrant.

Breast Cancer Incidence Rates Increase for Racial/Ethnic and Age Groups Between 2010 to 2016
October 19, 2020

A recent examination of breast cancer subtypes, specifically luminal A and luminal B breast cancer, found that incidence rates from 2010-2016 increased for a number of racial/ethnic and age groups.

Hospitals Serving Primarily Minority Patients Likely to Offer Standard of Surgical Care for Breast Cancer
October 13, 2020

Among accredited US cancer centers, hospitals which serve primarily minority patients were found to be as likely as other hospitals to offer the standard of surgical care for early-stage breast cancer.